The group's principal activity is to acquire and integrate into a collaborative network, companies operating in the field of pharmaceuticals, nutraceuticals and biotechnology. The group will leverage the benefits of its public status, the knowledge of its executive management team and access to capital resources of its strategic investors to assist in developing the business strategies, operations and management teams of companies it acquires. The group acquired quality botanical ingredients, inc on 25-Feb-2003.
